Raymond James & Associates’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,908
Closed -$598K 3812
2018
Q2
$598K Sell
6,908
-2,024
-23% -$162K ﹤0.01% 2548
2018
Q1
$709K Sell
8,932
-90,448
-91% -$7.9M ﹤0.01% 2349
2017
Q4
$8.33M Sell
99,380
-8,798
-8% -$681K 0.02% 861
2017
Q3
$7.13M Sell
108,178
-18,262
-14% -$1.16M 0.01% 909
2017
Q2
$7.86M Sell
126,440
-5,837
-4% -$408K 0.02% 824
2017
Q1
$9.48M Buy
132,277
+10,982
+9% +$735K 0.02% 700
2016
Q4
$7.57M Sell
121,295
-16,138
-12% -$931K 0.02% 768
2016
Q3
$8M Buy
137,433
+21,497
+19% +$1.08M 0.02% 717
2016
Q2
$4.47M Buy
115,936
+13,025
+13% +$644K 0.01% 910
2016
Q1
$6.29M Sell
102,911
-16,572
-14% -$957K 0.02% 710
2015
Q4
$7.85M Sell
119,483
-85,689
-42% -$5.78M 0.03% 621
2015
Q3
$12.6M Sell
205,172
-12,468
-6% -$831K 0.05% 405
2015
Q2
$15M Buy
217,640
+24,859
+13% +$1.74M 0.06% 381
2015
Q1
$13.7M Buy
192,781
+8,810
+5% +$572K 0.06% 346
2014
Q4
$11.4M Buy
183,971
+102,810
+127% +$5.44M 0.06% 364
2014
Q3
$4.04M Buy
81,161
+11,813
+17% +$598K 0.02% 733
2014
Q2
$3.44M Sell
69,348
-233
-0.3% -$10.7K 0.02% 804
2014
Q1
$3.04M Buy
69,581
+2,661
+4% +$105K 0.02% 798
2013
Q4
$2.31M Buy
66,920
+15,246
+30% +$571K 0.02% 870
2013
Q3
$2.13M Buy
51,674
+1,213
+2% +$45.7K 0.02% 847
2013
Q2
$1.78M Buy
+50,461
New +$1.68M 0.02% 868

Raymond James & Associates's CAVM Position: Q3 2018 in Review

Raymond James & Associates sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 6,908 shares — an estimated $598K sold.

Raymond James & Associates first reported a position in CAVM in Q2 2013 and held it in 21 quarters. The position peaked at $15M in Q2 2015. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.

  • Raymond James & Associates reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
  • Raymond James & Associates sold 6,908 Cavium, Inc. shares in Q3 2018, an estimated $598K.
  • Raymond James & Associates first reported a position in Cavium, Inc. in Q2 2013 and held it in 21 quarters.
  • Raymond James & Associates's Cavium, Inc. position peaked at $15M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.